Psychedelic Drug Development Digital Summit

When:
Wednesday, Oct 21, 2020 2:00p -
Thursday, Oct 22, 2020 8:00p

Where:
Online
United States
Online, MA 00000

EventScheduled OfflineEventAttendanceMode

Admission:
$1600

Categories:
Lectures & Conferences

Event website:
http://go.evvnt.com/678365-2?pid=5248

The use of psychedelic compounds has been met with controversy, and the industry faces unique barriers to development and access. As the burden of clinical efficacy evidence grows, the industry has seen an explosion in interest by pharma, biotech and the investment community.


The inaugural Psychedelic Drug Development Digital Summit will gather the best and brightest minds harnessing natural and synthetic psychoactive substances to treat depression, addiction, anxiety and many more life debilitating psychiatric conditions.


Join the Psychedelic Drug Development Summit to:


• Optimize novel drug development in expanded indications with Psilera Bioscience, Sansero Life Science, and Eleusis Ltd. Investigate the fundamental biology of psychedelic drugs and how to apply this knowledge to therapeutic design


• Advance your clinical success with AWAKN Life Sciences, DemeRX, The Beckley Foundation, and more. Hear industry consensus on clinical best practice, trial set up and scale, investigating novel indications and dose escalation to demonstrate safety and efficacy


• Address stigma, discuss education, and drive policy change to deliver life-changing psychedelic therapies with MindMed, MAPS, Government organizations, and more. Learn how leaders are working to develop a robust to-market strategy in 2020 and beyond


https://psychedelic-drug-development.com/


October 21-22, 2020


9am-3pm EST | 6am-12pm PDT | 2pm-8pm GMT


Contact:


[email protected]


URLs:
Brochure https://go.evvnt.com/678365-0?pid=5248
Tickets https://go.evvnt.com/678365-1?pid=5248


Prices:
Industry Pricing - Earlybird rates available: USD 1600.0
Academic Pricing - Earlybird rates available: USD 1100.0


Speakers: Amanda Feilding, Executive Director and Founder, The Beckley Foundation, Ben Sessa, Chief Medical Officer, AWAKN Life Sciences, Deborah Mash, CEO and Founder, DemeRX, George Goldsmith, CEO and Cofounder, COMPASS Pathways, Jacqueline von Salm, Co-Founder and CSO, Psilera Bioscience, Rick Doblin, Founder and Executive Director, MAPS

Share this event

Add to:

Reddit
10/21/2020 14:00:00 10/22/2020 20:00:00 America/New_York Psychedelic Drug Development Digital Summit The use of psychedelic compounds has been met with controversy, and the industry faces unique barriers to development and access. As the burden of clinical efficacy evidence grows, the industry has... Online, Online, MA 00000 false MM/DD/YYYY

Sponsored events